Letters

Medical student electives and infectious diseases

BMJ 1999; 318 doi: https://doi.org/10.1136/bmj.318.7191.1145b (Published 24 April 1999) Cite this as: BMJ 1999;318:1145

Zidovudine alone is not recommended prophylaxis

  1. Jeanette Meadway, Director of clinical services (meadj@dial.pipex.com)
  1. Mildmay Hospital UK, London E2 7NA
  2. Royal Hallamshire Hospital, Sheffield S10 2JF

    EDITOR—Gamester et al found that only 34% of students visiting a country with a high prevalence of HIV purchased zidovudine, probably because of the cost (£40). They recommended that medical schools should consider paying for the drug.1

    However, zidovudine alone is no longer the standard postexposure prophylaxis. United Kingdom guidelines now state that healthcare workers with high risk exposure to HIV should be advised to take a combination …

    View Full Text

    Sign in

    Log in through your institution

    Subscribe